The effect of Pharmaceutical care on Chronic Obstructive Pulmonary Disease patients, Banthi District, Lumphun Province
Article Sidebar
Main Article Content
Abstract
The Effect of Pharmaceutical Care on Chronic Obstructive Pulmonary Disease Patients, Banthi Hospital, Lumphun Province
Abstract
Black ground : Chronic Obstructive Pulmonary Disease (COPD) is public health problem in many country of the world including Thailand. Effective treatment of COPD consists of many factors such as drug compliance, inhalation technique, quit smoking, pulmonary rehabilitation. Then pharmacist should be take action pharmaceutical care to promote safe drug use, prevent and solve problems from medication. Increase quality of care and has good treatment results.
Objectives : To evaluate the effectiveness of pharmaceutical care on chronic obstructive pulmonary disease patients, including 1) drug compliance, 2) precision of using inhalation technique, 3) the number of hospitalization with exacerbation, 4) the number of receiving service at emergency room with exacerbation, 5) economic outcomes 6) quality of life.
Methods : This study was quasi-experimental research design. Eighty chronic obstructive pulmonary disease patients at Banthi district in Lumphun province, who receiving service at Banthi hospital, were selected during January-June, 2019. They were divided into two groups named Pharmaceutical care (Experimental group) and Non – pharmaceutical care (control group). Each group had 40 patients. The data were collected using approved instruments. They were interview forms for patients’ characteristics and illness, assessment forms for drug compliance and precision of using inhalation technique, and questionnaire form for patients’ quality of life. The data were analyzed using descriptive statistics and comparing experimental group and control group by fisher exact probability test, chi-square test and independent t – test.
Results: At the beginning of the research, there were no significant difference in patients’ characteristics of both groups. But after of pharmaceutical care, the results showed that at the end of study, patients in the experimental group had significantly higher score on drug compliance, had more precision of using inhalation technique, had significantly lower number of hospitalization and receiving service at emergency room because of exacerbation, and lastly had significantly better economic outcomes and quality of life than those in the control group (p< 0.01 to p< 0.05).
Conclusions and discussions : Regarding the results of this research, it may be inferred that pharmacists should take action pharmaceutical care with COPD patients continuously and expand another non-chronic disease patients.
Keywords: Pharmaceutical care, Effects of pharmaceutical care, Patients with COPD
Article Details
References
2. Banthi hospital medical record department medical statistic section. Number of chronic obstructive pulmonary disease patients and dead case 2015 - 2017. 2018.
3. Boonsawat W. Easy Chronic obstructive pulmonary disease Treatment. Bangkok: Kalangnanawitays; 2012.
4. Boonsung P. Effectiveness of Self-management Educational Program for Chronic Obstructive Pulmonary Disease Patients at RongKwang Hospital, Phrae Province. [Thesis for Master of Pharmacy]. (Clinical Pharmacy). Chiangmai: Chiangmai university; 2012.
5. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. [Internet]. 2018. Available from: https://www.goldcopd.org.
6. Jarab AS, Alqudah SG, Khdour M, Shamssain M, Mukattash TL. Impact of pharmaceutical care on health outcome in patient with COPD. Int J Clin Pharm . 2012; 34:53-62.
7. Kozma CM, Reeder CE, Schulz RM. Economic, Clinical, and Humanistic Outcomes : a planning Model for Pharmacoeconomic research. Advances in Lung Cancer Journal. 1993; 6(2):1121-32.
8. Kunwalairat P, Mayases P, Thongdang P. Assessment of pharmaceutical care outcomes on the patients with chronic obstructive pulmonary disease attending community hospital in Thailand. IJPS 2014;10 (1): 80.
9. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality form 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. 2012; 380(9859): 2095-128.
10. Ministry of Public Health. Gide line for Emergency room service delivery in hospital. Nonburi: Samchi group 2017 printing; 2018.
11. Ministry of Public Health. HDC-Report. Indicators of the Ministry of non-communicable Chronic Obstructive Pulmonary Disease. [Internet]. 2018 [cited 2019 May 8]. Available from: https://www.google.co.th/search?ei=T25UW indicator COPD.
12. Murnpa R. Continuity of Care in Primary Care Unit. [Internet]. 2012. Available from: https://www.thaihealthconsumer.org/book/.
13. Nation Health Security Office (NHSO). Public health service gideline 2010. Bankok: Srinuang – printing co.Ltd.; 2010.
14. Pummangkul CH. Pharmaceutical care : Concept and practice for today pharmacists. Bankok: Prachachon co, Ltd.; 2008.
15. Rakwannawong A. Drug-Related Problems and problem – Solving Outcomes of Out - Patients Chronic Obstructive Pulmonary Disease in Nakornping Hospital. [Thesis for Master of Pharmacy]. (Clinical Pharmacy). Chiangmai: Chiangmai University; 2012.
16. Sanguansak S, Sonsingh W, Niwatananun K. Outcomes of Pharmaceutical Care Development in Pediatric Patients with Thalassemia Using Deferiprone in Phrae Hospital. IJPS. 2019; 12(1): 13-24.
17. Sirikun P, Puttapitukpol S, Sangmanee R. The effect of caring model for patients with chronic obstructive pulmonary disease in the community after discharge from Sungaipadi hospital, Narathiwas province. Thai Journal of Cardio-Thoracic Nursing. 2017; 28(1): 59-67.
18. Throacic Society of Thailand under Royal Patronage. Health service Practice Guideline Chronic Obstructive Pulmonary Disease 2017. Bankok: Beyond Enterprize Company; 2017.
19. Tommelein E, Mehuys E, Vanhees T, Adriaens E, Van Bortel L, Christiaens T, et al. Effectiveness of pharmaceutical care for patients with chronic obstructive pulmonary disease (PHARMACOP). British Journal of Clinical Pharmacology. Belgium. 2013; 77(5): 756-766.
20. World Health Organization (WHO). Chronic obstructive pulmonary disease (COPD) [Internet]. 2017 [cited 2019 May 8]. Available from: https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd)?fbclid=IwAR0zf_HVECL_2OIVlRKUZ5iqHkieGdXaB53JHaI3jxBk F3kDyR_MCfClZGE.
